Gene · 143384
Papers3,620
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 3,620
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Research advancements regarding the relationship between FBXO2 and malignant tumors (Review). | Mol Med Rep | 2025 | 40999994 | PubTator, text mining | PubMed |
| UBR5: A New Player in Protein Quality Control for Skeletal Muscle Growth and Remodeling. | Exerc Sport Sci Rev | 2025 | 40993048 | PubTator, text mining | PubMed |
| FBXO9 mediated the ubiquitination and degradation of YAP in a GSK-3β-dependent manner. | J Biol Chem | 2025 | 40902979 | PubTator, text mining | PubMed |
| Characterization of PROTAC specificity and endogenous protein interactomes using ProtacID. | Nat Commun | 2025 | 40883309 | PubTator, text mining | PubMed |
| Dual functionality of MDM2 in PROTACs expands the horizons of targeted protein degradation. | Biomark Res | 2025 | 40866949 | PubTator, text mining | PubMed |
| Partners in Silencing: Decoding the Mammalian Argonaute Interactome. | Noncoding RNA | 2025 | 40863728 | PubTator, text mining | PubMed |
| The COP9 signalosome variants CSNCSN7A and CSNCSN7B form complexes with specific CRLs which are targets of autophagy. | Essays Biochem | 2025 | 40857740 | PubTator, text mining | PubMed |
| Multi-omics analysis reveals RNA polymerase II degradation as a novel mechanism of PF-3758309's anti-tumor activity. | Cell Death Discov | 2025 | 40854914 | PubTator, text mining | PubMed |
| Phosphorylation-Mediated Regulation of FBXO31 Stability Under Cellular Homeostasis. | Adv Biol (Weinh) | 2025 | 40847744 | PubTator, text mining | PubMed |
| Mechanistic Insights Into the Tumor-Driving and Diagnostic Roles of KCTD Family Genes in Ovarian Cancer: An Integrated In Silico and In Vitro Analysis. | Cancer Med | 2025 | 40832836 | PubTator, text mining | PubMed |
| Cul5Wsb2 uses BCL2 proteins as co-receptors to target Bim for degradation. | bioRxiv | 2025 | 40832228 | PubTator, text mining | PubMed |
| Chimerolectins: Classification, structural architecture, and functional perspectives. | Protein Sci | 2025 | 40815298 | PubTator, text mining | PubMed |
| Discovery of Novel Potent Triple IKZF1/2/3 Degraders for the Treatment of Hematological Cancers. | J Med Chem | 2025 | 40747902 | PubTator, text mining | PubMed |
| A Molecular Recruitment Colocalization Platform for Visualizing Multi-Protein Interactions and Engineering Biomolecular Condensates in Living Cells. | Adv Sci (Weinh) | 2025 | 40692378 | PubTator, text mining | PubMed |
| Persicaria minor F-box protein, PmFBK2 targeted by miR156a in response to MeJA treatment, potentially affects stress-related proteins. | J Plant Physiol | 2025 | 40683030 | PubTator, text mining | PubMed |
| Fbxo2 inhibits cell proliferation, migration and invasion by the ubiquitin-mediated degradation of WEE1 in renal cell carcinoma. | Cell Oncol (Dordr) | 2025 | 40676478 | PubTator, text mining | PubMed |
| Novel Highly Potent c-Met Degraders against a Broad Range of Cancers. | J Med Chem | 2025 | 40665847 | PubTator, text mining | PubMed |
| Functional characterisation of components in two Plasmodium falciparum Cullin-RING-Ligase complexes. | Sci Rep | 2025 | 40592953 | PubTator, text mining | PubMed |
| Structural mechanism for the recognition of E2F1 by the ubiquitin ligase adaptor Cyclin F. | Proc Natl Acad Sci U S A | 2025 | 40549918 | PubTator, text mining | PubMed |
| Analysis of cullin family genes in rectal adenocarcinoma: expression, prognostic significance, and therapeutic implications. | Am J Transl Res | 2025 | 40535676 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/143384/papers?page=4